Harry Glorikian
InvestorGeneral Partner at Scientia Ventures
About
Harry Glorikian is a General Partner at Scientia Ventures and a Research Affiliate at the MIT Media Lab, with over three decades of experience building, investing in, and advising companies across healthcare, life sciences, and data-driven technology. He previously served as an Entrepreneur-in-Residence at GE Ventures' New Business Creation Group, where he co-founded Evidation Health and DrawBridge Health, and earlier co-founded and led Scientia Advisors, which Precision for Medicine acquired in 2012. He is the author of four books and hosts a podcast on AI and the data-driven transformation of healthcare, and holds an MBA from Boston University and a bachelor's degree from San Francisco State University.
Invests in
AI & Machine LearningBiotechDigital HealthHealthtech
Deals · 1
GenenewsBoard seat
via Scientia Ventures · filed Jul 2017 · $245.6K raise
Attribution from SEC filings, press coverage, and firm rosters.
